Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Beijing InnoCare Pharma Tech Co., Ltd.
Scientific Title
A Multi-center Open-label, Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ICP-192 in Patients With Advanced Solid Tumors and FGFR Gene Alterations